2018 -- S 2540 SUBSTITUTE A | |
======== | |
LC004935/SUB A | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2018 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE - INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE ABUSE | |
| |
Introduced By: Senators Seveney, Coyne, Miller, DiPalma, and Calkin | |
Date Introduced: March 01, 2018 | |
Referred To: Senate Health & Human Services | |
(Governor) | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 27-38.2-1 of the General Laws in Chapter 27-38.2 entitled |
2 | "Insurance Coverage for Mental Illness and Substance Abuse" is hereby amended to read as |
3 | follows: |
4 | 27-38.2-1. Coverage for treatment of mental health and substance use disorders. |
5 | [Effective April 1, 2018.]. |
6 | (a) A group health plan and an individual or group health insurance plan shall provide |
7 | coverage for the treatment of mental health and substance-use disorders under the same terms and |
8 | conditions as that coverage is provided for other illnesses and diseases. |
9 | (b) Coverage for the treatment of mental health and substance-use disorders shall not |
10 | impose any annual or lifetime dollar limitation. |
11 | (c) Financial requirements and quantitative treatment limitations on coverage for the |
12 | treatment of mental health and substance-use disorders shall be no more restrictive than the |
13 | predominant financial requirements applied to substantially all coverage for medical conditions in |
14 | each treatment classification. |
15 | (d) Coverage shall not impose non-quantitative treatment limitations for the treatment of |
16 | mental health and substance-use disorders unless the processes, strategies, evidentiary standards, |
17 | or other factors used in applying the non-quantitative treatment limitation, as written and in |
18 | operation, are comparable to, and are applied no more stringently than, the processes, strategies, |
| |
1 | evidentiary standards, or other factors used in applying the limitation with respect to |
2 | medical/surgical benefits in the classification. |
3 | (e) The following classifications shall be used to apply the coverage requirements of this |
4 | chapter: (1) Inpatient, in-network; (2) Inpatient, out-of-network; (3) Outpatient, in-network; (4) |
5 | Outpatient, out-of-network; (5) Emergency care; and (6) Prescription drugs. |
6 | (f) Medication-assisted treatment or medication-assisted maintenance services of |
7 | substance-use disorders, opioid overdoses, and chronic addiction, including methadone, |
8 | buprenorphine, naltrexone, or other clinically appropriate medications, is included within the |
9 | appropriate classification based on the site of the service. |
10 | (g) Payors shall rely upon the criteria of the American Society of Addiction Medicine |
11 | when developing coverage for levels of care for substance-use disorder treatment. |
12 | (h) Patients with substance-use disorders shall have access to evidence-based, non-opioid |
13 | treatment for pain, therefore coverage shall apply to medically necessary chiropractic care and |
14 | osteopathic manipulative treatment performed by an individual licensed under § 5-37-2. |
15 | (i) Parity of cost-sharing requirements. Regardless of the professional license of the |
16 | provider of care, if that care is consistent with the provider's scope of practice and the health |
17 | plan's credentialing and contracting provisions, cost-sharing for behavioral health counseling |
18 | visits and medication maintenance visits shall be consistent with the cost-sharing applied to |
19 | primary care office visits. |
20 | SECTION 2. Section 42-14.5-3 of the General Laws in Chapter 42-14.5 entitled "The |
21 | Rhode Island Health Care Reform Act of 2004 - Health Insurance Oversight" is hereby amended |
22 | to read as follows: |
23 | 42-14.5-3. Powers and duties [Contingent effective date; see effective dates under |
24 | this section. Powers and duties [Contingent effective date; see effective dates under this |
25 | section.] |
26 | The health insurance commissioner shall have the following powers and duties: |
27 | (a) To conduct quarterly public meetings throughout the state, separate and distinct from |
28 | rate hearings pursuant to § 42-62-13, regarding the rates, services, and operations of insurers |
29 | licensed to provide health insurance in the state; the effects of such rates, services, and operations |
30 | on consumers, medical care providers, patients, and the market environment in which such |
31 | insurers operate; and efforts to bring new health insurers into the Rhode Island market. Notice of |
32 | not less than ten (10) days of said hearing(s) shall go to the general assembly, the governor, the |
33 | Rhode Island Medical Society, the Hospital Association of Rhode Island, the director of health, |
34 | the attorney general, and the chambers of commerce. Public notice shall be posted on the |
| LC004935/SUB A - Page 2 of 9 |
1 | department's web site and given in the newspaper of general circulation, and to any entity in |
2 | writing requesting notice. |
3 | (b) To make recommendations to the governor and the house of representatives and |
4 | senate finance committees regarding health-care insurance and the regulations, rates, services, |
5 | administrative expenses, reserve requirements, and operations of insurers providing health |
6 | insurance in the state, and to prepare or comment on, upon the request of the governor or |
7 | chairpersons of the house or senate finance committees, draft legislation to improve the regulation |
8 | of health insurance. In making such recommendations, the commissioner shall recognize that it is |
9 | the intent of the legislature that the maximum disclosure be provided regarding the |
10 | reasonableness of individual administrative expenditures as well as total administrative costs. The |
11 | commissioner shall make recommendations on the levels of reserves, including consideration of: |
12 | targeted reserve levels; trends in the increase or decrease of reserve levels; and insurer plans for |
13 | distributing excess reserves. |
14 | (c) To establish a consumer/business/labor/medical advisory council to obtain |
15 | information and present concerns of consumers, business, and medical providers affected by |
16 | health-insurance decisions. The council shall develop proposals to allow the market for small |
17 | business health insurance to be affordable and fairer. The council shall be involved in the |
18 | planning and conduct of the quarterly public meetings in accordance with subsection (a). The |
19 | advisory council shall develop measures to inform small businesses of an insurance complaint |
20 | process to ensure that small businesses that experience rate increases in a given year may request |
21 | and receive a formal review by the department. The advisory council shall assess views of the |
22 | health-provider community relative to insurance rates of reimbursement, billing, and |
23 | reimbursement procedures, and the insurers' role in promoting efficient and high-quality health |
24 | care. The advisory council shall issue an annual report of findings and recommendations to the |
25 | governor and the general assembly and present its findings at hearings before the house and |
26 | senate finance committees. The advisory council is to be diverse in interests and shall include |
27 | representatives of community consumer organizations; small businesses, other than those |
28 | involved in the sale of insurance products; and hospital, medical, and other health-provider |
29 | organizations. Such representatives shall be nominated by their respective organizations. The |
30 | advisory council shall be co-chaired by the health insurance commissioner and a community |
31 | consumer organization or small business member to be elected by the full advisory council. |
32 | (d) To establish and provide guidance and assistance to a subcommittee ("the |
33 | professional-provider-health-plan work group") of the advisory council created pursuant to |
34 | subsection (c), composed of health-care providers and Rhode Island licensed health plans. This |
| LC004935/SUB A - Page 3 of 9 |
1 | subcommittee shall include in its annual report and presentation before the house and senate |
2 | finance committees the following information: |
3 | (1) A method whereby health plans shall disclose to contracted providers the fee |
4 | schedules used to provide payment to those providers for services rendered to covered patients; |
5 | (2) A standardized provider application and credentials-verification process, for the |
6 | purpose of verifying professional qualifications of participating health-care providers; |
7 | (3) The uniform health plan claim form utilized by participating providers; |
8 | (4) Methods for health maintenance organizations, as defined by § 27-41-2, and nonprofit |
9 | hospital or medical-service corporations, as defined by chapters 19 and 20 of title 27, to make |
10 | facility-specific data and other medical service-specific data available in reasonably consistent |
11 | formats to patients regarding quality and costs. This information would help consumers make |
12 | informed choices regarding the facilities and/or clinicians or physician practices at which to seek |
13 | care. Among the items considered would be the unique health services and other public goods |
14 | provided by facilities and/or clinicians or physician practices in establishing the most appropriate |
15 | cost comparisons; |
16 | (5) All activities related to contractual disclosure to participating providers of the |
17 | mechanisms for resolving health plan/provider disputes; |
18 | (6) The uniform process being utilized for confirming, in real time, patient insurance |
19 | enrollment status, benefits coverage, including co-pays and deductibles; |
20 | (7) Information related to temporary credentialing of providers seeking to participate in |
21 | the plan's network and the impact of said activity on health-plan accreditation; |
22 | (8) The feasibility of regular contract renegotiations between plans and the providers in |
23 | their networks; and |
24 | (9) Efforts conducted related to reviewing impact of silent PPOs on physician practices. |
25 | (e) To enforce the provisions of Title 27 and Title 42 as set forth in § 42-14-5(d). |
26 | (f) To provide analysis of the Rhode Island affordable health plan reinsurance fund. The |
27 | fund shall be used to effectuate the provisions of §§ 27-18.5-9 and 27-50-17. |
28 | (g) To analyze the impact of changing the rating guidelines and/or merging the individual |
29 | health-insurance market as defined in chapter 18.5 of title 27 and the small-employer-health- |
30 | insurance market as defined in chapter 50 of title 27 in accordance with the following: |
31 | (1) The analysis shall forecast the likely rate increases required to effect the changes |
32 | recommended pursuant to the preceding subsection (g) in the direct-pay market and small- |
33 | employer-health-insurance market over the next five (5) years, based on the current rating |
34 | structure and current products. |
| LC004935/SUB A - Page 4 of 9 |
1 | (2) The analysis shall include examining the impact of merging the individual and small- |
2 | employer markets on premiums charged to individuals and small-employer groups. |
3 | (3) The analysis shall include examining the impact on rates in each of the individual and |
4 | small-employer-health-insurance markets and the number of insureds in the context of possible |
5 | changes to the rating guidelines used for small-employer groups, including: community rating |
6 | principles; expanding small-employer rate bonds beyond the current range; increasing the |
7 | employer group size in the small-group market; and/or adding rating factors for broker and/or |
8 | tobacco use. |
9 | (4) The analysis shall include examining the adequacy of current statutory and regulatory |
10 | oversight of the rating process and factors employed by the participants in the proposed, new |
11 | merged market. |
12 | (5) The analysis shall include assessment of possible reinsurance mechanisms and/or |
13 | federal high-risk pool structures and funding to support the health-insurance market in Rhode |
14 | Island by reducing the risk of adverse selection and the incremental insurance premiums charged |
15 | for this risk, and/or by making health insurance affordable for a selected at-risk population. |
16 | (6) The health insurance commissioner shall work with an insurance market merger task |
17 | force to assist with the analysis. The task force shall be chaired by the health insurance |
18 | commissioner and shall include, but not be limited to, representatives of the general assembly, the |
19 | business community, small-employer carriers as defined in § 27-50-3, carriers offering coverage |
20 | in the individual market in Rhode Island, health-insurance brokers, and members of the general |
21 | public. |
22 | (7) For the purposes of conducting this analysis, the commissioner may contract with an |
23 | outside organization with expertise in fiscal analysis of the private-insurance market. In |
24 | conducting its study, the organization shall, to the extent possible, obtain and use actual health- |
25 | plan data. Said data shall be subject to state and federal laws and regulations governing |
26 | confidentiality of health care and proprietary information. |
27 | (8) The task force shall meet as necessary and include its findings in the annual report, |
28 | and the commissioner shall include the information in the annual presentation before the house |
29 | and senate finance committees. |
30 | (h) To establish and convene a workgroup representing health-care providers and health |
31 | insurers for the purpose of coordinating the development of processes, guidelines, and standards |
32 | to streamline health-care administration that are to be adopted by payors and providers of health- |
33 | care services operating in the state. This workgroup shall include representatives with expertise |
34 | who would contribute to the streamlining of health-care administration and who are selected from |
| LC004935/SUB A - Page 5 of 9 |
1 | hospitals, physician practices, community behavioral-health organizations, each health insurer, |
2 | and other affected entities. The workgroup shall also include at least one designee each from the |
3 | Rhode Island Medical Society, Rhode Island Council of Community Mental Health |
4 | Organizations, the Rhode Island Health Center Association, and the Hospital Association of |
5 | Rhode Island. The workgroup shall consider and make recommendations for: |
6 | (1) Establishing a consistent standard for electronic eligibility and coverage verification. |
7 | Such standard shall: |
8 | (i) Include standards for eligibility inquiry and response and, wherever possible, be |
9 | consistent with the standards adopted by nationally recognized organizations, such as the Centers |
10 | for Medicare and Medicaid Services; |
11 | (ii) Enable providers and payors to exchange eligibility requests and responses on a |
12 | system-to-system basis or using a payor-supported web browser; |
13 | (iii) Provide reasonably detailed information on a consumer's eligibility for health-care |
14 | coverage; scope of benefits; limitations and exclusions provided under that coverage; cost-sharing |
15 | requirements for specific services at the specific time of the inquiry; current deductible amounts; |
16 | accumulated or limited benefits; out-of-pocket maximums; any maximum policy amounts; and |
17 | other information required for the provider to collect the patient's portion of the bill; |
18 | (iv) Reflect the necessary limitations imposed on payors by the originator of the |
19 | eligibility and benefits information; |
20 | (v) Recommend a standard or common process to protect all providers from the costs of |
21 | services to patients who are ineligible for insurance coverage in circumstances where a payor |
22 | provides eligibility verification based on best information available to the payor at the date of the |
23 | request of eligibility. |
24 | (2) Developing implementation guidelines and promoting adoption of such guidelines |
25 | for: |
26 | (i) The use of the National Correct Coding Initiative code-edit policy by payors and |
27 | providers in the state; |
28 | (ii) Publishing any variations from codes and mutually exclusive codes by payors in a |
29 | manner that makes for simple retrieval and implementation by providers; |
30 | (iii) Use of Health Insurance Portability and Accountability Act standard group codes, |
31 | reason codes, and remark codes by payors in electronic remittances sent to providers; |
32 | (iv) The processing of corrections to claims by providers and payors. |
33 | (v) A standard payor-denial review process for providers when they request a |
34 | reconsideration of a denial of a claim that results from differences in clinical edits where no |
| LC004935/SUB A - Page 6 of 9 |
1 | single, common-standards body or process exists and multiple conflicting sources are in use by |
2 | payors and providers. |
3 | (vi) Nothing in this section, nor in the guidelines developed, shall inhibit an individual |
4 | payor's ability to employ, and not disclose to providers, temporary code edits for the purpose of |
5 | detecting and deterring fraudulent billing activities. The guidelines shall require that each payor |
6 | disclose to the provider its adjudication decision on a claim that was denied or adjusted based on |
7 | the application of such edits and that the provider have access to the payor's review and appeal |
8 | process to challenge the payor's adjudication decision. |
9 | (vii) Nothing in this subsection shall be construed to modify the rights or obligations of |
10 | payors or providers with respect to procedures relating to the investigation, reporting, appeal, or |
11 | prosecution under applicable law of potentially fraudulent billing activities. |
12 | (3) Developing and promoting widespread adoption by payors and providers of |
13 | guidelines to: |
14 | (i) Ensure payors do not automatically deny claims for services when extenuating |
15 | circumstances make it impossible for the provider to obtain a preauthorization before services are |
16 | performed or notify a payor within an appropriate standardized timeline of a patient's admission; |
17 | (ii) Require payors to use common and consistent processes and time frames when |
18 | responding to provider requests for medical management approvals. Whenever possible, such |
19 | time frames shall be consistent with those established by leading national organizations and be |
20 | based upon the acuity of the patient's need for care or treatment. For the purposes of this section, |
21 | medical management includes prior authorization of services, preauthorization of services, |
22 | precertification of services, post-service review, medical-necessity review, and benefits advisory; |
23 | (iii) Develop, maintain, and promote widespread adoption of a single, common website |
24 | where providers can obtain payors' preauthorization, benefits advisory, and preadmission |
25 | requirements; |
26 | (iv) Establish guidelines for payors to develop and maintain a website that providers can |
27 | use to request a preauthorization, including a prospective clinical necessity review; receive an |
28 | authorization number; and transmit an admission notification. |
29 | (4) To provide a report to the house and senate, on or before January 1, 2017, with |
30 | recommendations for establishing guidelines and regulations for systems that give patients |
31 | electronic access to their claims information, particularly to information regarding their |
32 | obligations to pay for received medical services, pursuant to 45 C.F.R. 164.524. |
33 | (i) To issue an anti-cancer medication report. Not later than June 30, 2014 and annually |
34 | thereafter, the office of the health insurance commissioner (OHIC) shall provide the senate |
| LC004935/SUB A - Page 7 of 9 |
1 | committee on health and human services, and the house committee on corporations, with: (1) |
2 | Information on the availability in the commercial market of coverage for anti-cancer medication |
3 | options; (2) For the state employee's health benefit plan, the costs of various cancer-treatment |
4 | options; (3) The changes in drug prices over the prior thirty-six (36) months; and (4) Member |
5 | utilization and cost-sharing expense. |
6 | (j) To monitor the adequacy of each health plan's compliance with the provisions of the |
7 | federal Mental Health Parity Act, including a review of related claims processing and |
8 | reimbursement procedures. Findings, recommendations, and assessments shall be made available |
9 | to the public. |
10 | (k) To monitor the transition from fee-for-service and toward global and other alternative |
11 | payment methodologies for the payment for health-care services. Alternative payment |
12 | methodologies should be assessed for their likelihood to promote access to affordable health |
13 | insurance, health outcomes, and performance. |
14 | (l) To report annually, no later than July 1, 2014, then biannually thereafter, on hospital |
15 | payment variation, including findings and recommendations, subject to available resources. |
16 | (m) Notwithstanding any provision of the general or public laws or regulation to the |
17 | contrary, provide a report with findings and recommendations to the president of the senate and |
18 | the speaker of the house, on or before April 1, 2014, including, but not limited to, the following |
19 | information: |
20 | (1) The impact of the current, mandated health-care benefits as defined in §§ 27-18-48.1, |
21 | 27-18-60, 27-18-62, 27-18-64, similar provisions in chapters 19, 20 and 41, of title 27, and §§ 27- |
22 | 18-3(c), 27-38.2-1 et seq., or others as determined by the commissioner, on the cost of health |
23 | insurance for fully insured employers, subject to available resources; |
24 | (2) Current provider and insurer mandates that are unnecessary and/or duplicative due to |
25 | the existing standards of care and/or delivery of services in the health-care system; |
26 | (3) A state-by-state comparison of health-insurance mandates and the extent to which |
27 | Rhode Island mandates exceed other states benefits; and |
28 | (4) Recommendations for amendments to existing mandated benefits based on the |
29 | findings in (m)(1), (m)(2), and (m)(3) above. |
30 | (n) On or before July 1, 2014, the office of the health insurance commissioner, in |
31 | collaboration with the director of health and lieutenant governor's office, shall submit a report to |
32 | the general assembly and the governor to inform the design of accountable care organizations |
33 | (ACOs) in Rhode Island as unique structures for comprehensive health-care delivery and value- |
34 | based payment arrangements, that shall include, but not be limited to: |
| LC004935/SUB A - Page 8 of 9 |
1 | (1) Utilization review; |
2 | (2) Contracting; and |
3 | (3) Licensing and regulation. |
4 | (o) On or before February 3, 2015, the office of the health insurance commissioner shall |
5 | submit a report to the general assembly and the governor that describes, analyzes, and proposes |
6 | recommendations to improve compliance of insurers with the provisions of § 27-18-76 with |
7 | regard to patients with mental-health and substance-use disorders. |
8 | (p) To work to ensure the health insurance coverage of behavioral health care under the |
9 | same terms and conditions as other health care, and to integrate behavioral health parity |
10 | requirements into the OHIC insurance oversight and health care transformation efforts. |
11 | (q) To work with other state agencies to seek delivery system improvements that enhance |
12 | access to a continuum of mental health and substance use disorder treatment in the state; and |
13 | integrate that treatment with primary and other medical care to the fullest extent possible. |
14 | (r) To direct insurers toward policies and practices that address the behavioral health |
15 | needs of the public and greater integration of physical and behavioral health care delivery. |
16 | (s) The office of the health insurance commissioner shall conduct an analysis of the |
17 | impact of the provisions of § 27-38.2-1 on health insurance premiums and access in Rhode Island |
18 | and submit a report of its findings to the general assembly on or before June 1, 2023. |
19 | SECTION 3. This act shall take effect upon passage, and Section 1 shall take effect for |
20 | all policies issued, revised, delivered, or renewed on or after January 1, 2019. |
======== | |
LC004935/SUB A | |
======== | |
| LC004935/SUB A - Page 9 of 9 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE - INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE ABUSE | |
*** | |
1 | This act would include behavioral health counseling visits and medication maintenance |
2 | visits as primary care visits for patient cost-sharing requirements under the provisions of a health |
3 | plan. |
4 | This act would take effect upon passage, and Section 1 would take effect for all policies |
5 | issued, revised, delivered, or renewed on or after January 1, 2019. |
======== | |
LC004935/SUB A | |
======== | |
| LC004935/SUB A - Page 10 of 9 |